drugset / Trial / NCT00392028

Penetration of Ertapenem Into Bone

NCT00392028

Withdrawn 12 enrolled HaEmek Medical Center, Israel
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The aim of the study is to determine the penetration levels of ertapenem into bone tissues in patients with Diabetes Mellitus (D.M) or Peripheral Vascular Diseases (P.V.D) undergoing amputation, and to correlate theme to the concentration of the drug in blood and other soft tissues

Timeline

Start
2006-11
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ertapenem Small molecule 1 g Intravenous

Indications

No indication recorded.